The Rogosin Institute Opens New Dialysis Center in Queens
[Queens, New York] - The Rogosin Institute is bringing dialysis closer to home for patients who need it by opening a new dialysis center in Auburndale, Queens. The Opening Reception, held Wednesday October 12, 2011 was attended by Helen Marshall, Queens Borough President, Paola Miceli, Director, Health , Human and Senior Services and other government officials. The center can accommodate 232 patients. In addition to dialysis, the center will provide home dialysis training and referrals for kidney transplantation.
More than 10 percent of Americans, or more than 20 million people, have chronic kidney disease and more than 380,000 have end stage kidney disease requiring dialysis*. Hemodialysis can take three to four hours, at least three times weekly, which can greatly impact a patient's lifestyle.
"While it may seem that, for many people, it is getting more challenging to access medical care, we are fortunate to be able to bring this necessary treatment into the neighborhoods of our patients," said Barry Smith, MD, President and CEO of The Rogosin Institute. "Dialysis can greatly impact an individual's lifestyle. Being able to access dialysis closer to home can help patients lead more productive and less disrupted lives. This new facility embodies Rogosin's commitment to provide the highest quality of care in the most convenient way possible for our patients."
"At a time when the entire healthcare industry is facing dire economic hardships, I am thankful to cut a ribbon on the opening of a center that will benefit 232 residents of Queens," remarked, Queens Borough President, Helen Marshall.
The 12,000-square-foot facility is staffed with 16 full-time medical professionals and will be open from 5:30 a.m. to 11 p.m., Monday through Saturday. The innovative design for the center provides more privacy and personal space for an optimal treatment setting
The facility was made possible with a challenge grant provided by Rogosin board members, William and Linda Macaulay. The Macaulays matched the first $750,000 raised for the project by Rogosin. The facility cost $3.5 million to build and equip.
Rogosin's dialysis capacity is expanding further with construction of a new dialysis facility located in the upper west side of Manhattan. This facility is expected to open in the Fall of 2012.
Rogosin is an independent not-for-profit treatment and research center affiliated with NewYork-Presbyterian Hospital (NYPH), Weill Cornell Medical College. It is a Sponsored Member of the NewYork-Presbyterian Healthcare System. Rogosin is one of the nation's leading centers for kidney disease, providing services from early stage disease to more serious problems requiring dialysis and transplantation. The Institute is unique in its combination of the best in clinical care with research into new and better ways to prevent and treat kidney disease, as well as the diseases that contribute to it, such as hypertension, diabetes, and lipid disorders.
*National Kidney & Urologic Diseases Information Clearinghouse (NKUDIC)